Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Roy Forster"'
Autor:
Michelle Dubuc-Mageau, Audrey Sanfacon, Andy Makin, Robert Tavcar, Christian Li, Luis Fernando Negro Silva, Roy Forster, Simon Authier, Paula Juliana Brizuela de Seadi Pereira, Wendy Tan
Publikováno v:
International Journal of Toxicology. 38:415-422
Minipigs are an emerging nonrodent alternative for ocular toxicology owing to anatomical similarities in the minipig eyes when compared to humans. Ocular structures and components from Göttingen minipigs were characterized and compared to species co
Autor:
Sisse Ellemann-Laursen, Katherine Hill, Judit Hargitai, Pramila Singh, Simon Authier, Roy Forster, Andy Makin, Francine Beaudry, Clémentine Pinêtre, Robert Tavcar, Anne Marie Downey, France-Hélène Paradis
Publikováno v:
International Journal of Toxicology. 38:476-486
Species-dependent differences in relative incidence of spontaneous variations and malformations should be considered in the assessment of the translational value of reproductive and developmental safety assessments. The objective of this evaluation w
Publikováno v:
Regulatory Toxicology and Pharmacology. 92:303-314
The aim of the present work was to evaluate the effects of photo-activated toxicity induced after administration of two known melanin-binding phototoxic compounds, sparfloxacin (SPX) and 8-methoxypsoralen (8-MOP), followed or not by UVA/Vis exposure,
Autor:
Virginie Modeste, Alizée Brient, Catherine Thirion-Delalande, Roy Forster, Corinne Aguenou, Hywel Griffiths, Olivier Cagnac
Publikováno v:
Toxicology Research and Application, Vol 3 (2019)
Protealg ® is the dried and ground whole biomass of Galdieria sulphuraria , a microalga naturally rich in protein and phycocyanin, and contains carotenoids. It is expected that Protealg will be consumed as a food ingredient or supplement by the gene
Autor:
Roy Forster, Bernard Palate, Catherine Thirion-Delalande, Frédéric Gervais, André Almeida Schenka
Publikováno v:
Toxicologic pathology. 47(2)
We describe here an angiomyomatous hamartoma in the right axillary lymph node of a three-year-old male cynomolgus monkey ( Macaca fascicularis), used as a control subject in a short-term toxicity study. This is a very rare lesion that has been report
Autor:
Walter Janssens, Jan Willem van der Laan, Elke Stahl, Joseph T. Brady, Jeroen Bos, Charles Benson, Ulla Wändel-Liminga, Beatriz Silva-Lima, Solange Corriol-Rohou, Roy Forster, Sarah Robertson, Andreas Hartmann, Salah-Dine Chibout, Raleigh E. Malik, Peter Pertel
Publikováno v:
Therapeutic innovationregulatory science. 54(2)
The EU is a member of the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH), and therefore adopts the ICH Guidelines, including the ICH M3 Guideline on Nonclinical Safety Studies. Following the
Autor:
Roy Forster, Francine El Amrani-Callens, Abdel-Ilah El Amrani, Stéphane Loriot, Pramila Singh
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 81:136-143
Introduction Cardiovascular safety assessment requires accurate evaluation of QT interval, which depends on the length of the cardiac cycle and also on core body temperature (BT). Increases in QT interval duration have been shown to be associated wit
Autor:
Abdel-Ilah El Amrani, Marie-Eve Duclos, Roy Forster, Stéphane Loriot, Pramila Singh, Francine El Amrani-Callens
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 105:106812
Autor:
Susan L. Greenwood, Neil J. Sebire, Roy Forster, Elena Olearo, Michelle Desforges, Carlo Rossi, Paul Brownbill, Alexandra Rogue, Mark Lees, Anna L. David, Nick Pearson, Colin P. Sibley
Publikováno v:
Desforges, M, Rogue, AR, Pearson, N, Rossi, C, Olearo, E, Forster, R, Lees, M, Sebire, N, Greenwood, S, Sibley, C, David, AL & Brownbill, P 2018, ' In vitro human placental studies to support an adenovirusmediated VEGF-DΔNΔC maternal gene therapy for the treatment of severe early-onset fetal growth restriction ', Human gene therapy. Clinical development . https://doi.org/10.1089/humc.2017.090
Severe fetal growth restriction (FGR) affects 1 in 500 pregnancies, is untreatable, and causes serious neonatal morbidity and death. Reduced uterine blood flow (UBF) is one cause. Transduction of u...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bbc14d1b6e41fb1c6ac8ffd1da56f91
https://doi.org/10.1089/humc.2017.090
https://doi.org/10.1089/humc.2017.090
Autor:
Michelle, Desforges, Alexandra, Rogue, Nick, Pearson, Carlo, Rossi, Elena, Olearo, Roy, Forster, Mark, Lees, Neil J, Sebire, Susan L, Greenwood, Colin P, Sibley, Anna L, David, Paul, Brownbill
Publikováno v:
Human gene therapy. Clinical development. 29(1)
Severe fetal growth restriction (FGR) affects 1 in 500 pregnancies, is untreatable, and causes serious neonatal morbidity and death. Reduced uterine blood flow (UBF) is one cause. Transduction of uterine arteries in normal and FGR animal models using